🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 774.83 +0.7% NASDAQ 100: 756.20 +0.9% Dow Jones: 534.08 -0.5%

Camrose Capital Investment Partners L - Q4 2025 13F Filings

CA

Camrose Capital Investment Partners Llp

CIK: 0002040608
Address: United Kingdom London 2Nd Floor, 21A, Kingly Street Carnaby
$603.8 M
Portfolio Value
10
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 08/14/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. MA Mastercard Incorporated
+$52.64 M
2. CNM Core & Main
+$25.35 M
3. SPGI S&P Global
+$20.56 M
4. TXN Texas Instruments Incorporated
+$20.09 M
5. MLM Martin Marietta Materials
+$11.22 M

Top Sells

Q4 2025

No sell transactions available for this period

Asset Allocation

Stocks/ETFs
+40.12%
$603.8 M 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Camrose Capital Investment Partners L Q4 2025 Filing Summary

Camrose Capital Investment Partners Llp filed its 13F report for Q4 2025 on February 17, 2026. The portfolio totaled 603.8 M reflecting a +40.12% change from the prior quarter, spanning 10 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 0 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Camrose Capital Investment Partners L’s Q4 2025 Filing

Camrose Capital Investment Partners L submitted their Form 13F-HR for the Q4 2025 period on 02/17/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Camrose Capital Investment Partners L reported a managed portfolio value of 603.8 M, consisting of 10 individual positions.

This page displays the raw filing documents. To see which stocks Camrose Capital Investment Partners L bought or sold during Q4 2025, please visit Camrose Capital Investment Partners L's Portfolio Analysis page.